Nationwide surveillance for S-Metoprololtreatment effect on blood pressure control against sympathetic overdrive in Indian patients with hypertension (PROTECT)

Ramesh, D.; Kumar, Parminder Singh; Palimkar, Priya; Dhoot, Krishna; Dabhade, Dhammdeep C.; Newale, Sanket.
Artículo | IMSEAR | ID: sea-225740

Documentos relacionados

  1. Hypertension in Young Adults in India: Perspectives and Therapeutic Options amongst Clinician's in a Cross Sectional Observational Study.
  2. Management of Hypertension in Patients with Diabetes: A Comprehensive Review of the Perceptions and Practices of Health Care Providers in India.
  3. A Retrospective Study to Evaluate Real-world Evidence of Azelnidipine in Indian Patients (REDEFINE Study).
  4. Research Letter: Antihypertensive Drugs Market in India: An Insight on Size, Trends, and Prescribing Preferences in the Private Health Sector, 2016-2018.
  5. Telmisartan Plus Amlodipine as the Preferred Initial Combination in Newly Diagnosed Indian Patients with Hypertension: An Expert Consensus Statements.
  6. Public reporting of black participation in anti-hypertensive drug clinical trials.
  7. Refractory Hypertension: a Narrative Systematic Review with Emphasis on Prognosis.
  8. Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified.
  9. Antihypertensive prescribing preferences in three South Indian Hospitals: cost analysis, physicians perspectives and emerging trends.
  10. Antihypertensive drugs in blood donations in Serbia - Observational study.